Review



bcg scar  (STATA Corporation)


Bioz Verified Symbol STATA Corporation is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 99
      Buy from Supplier

    Structured Review

    STATA Corporation bcg scar
    Characteristics of patients included in the cohort, with a detail of those responding and those not responding to ELISPOT PHA positive control.
    Bcg Scar, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 6309 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bcg scar/product/STATA Corporation
    Average 99 stars, based on 6309 article reviews
    bcg scar - by Bioz Stars, 2026-06
    99/100 stars

    Images

    1) Product Images from "Sensitivity of IFN-γ Release Assay to Detect Latent Tuberculosis Infection Is Retained in HIV-Infected Patients but Dependent on HIV/AIDS Progression"

    Article Title: Sensitivity of IFN-γ Release Assay to Detect Latent Tuberculosis Infection Is Retained in HIV-Infected Patients but Dependent on HIV/AIDS Progression

    Journal: PLoS ONE

    doi: 10.1371/journal.pone.0001441

    Characteristics of patients included in the cohort, with a detail of those responding and those not responding to ELISPOT PHA positive control.
    Figure Legend Snippet: Characteristics of patients included in the cohort, with a detail of those responding and those not responding to ELISPOT PHA positive control.

    Techniques Used: Enzyme-linked Immunospot, Control

    Analysis of the determinants of positive response to the ESAT6/CFP10 ELISPOT assay and to the TST (n = 247).
    Figure Legend Snippet: Analysis of the determinants of positive response to the ESAT6/CFP10 ELISPOT assay and to the TST (n = 247).

    Techniques Used: Enzyme-linked Immunospot, Infection



    Similar Products

    40 scar reactivation of old bcg vaccination scars after moderna covid 19 vaccine  (Moderna)
    86
    Moderna 40 scar reactivation of old bcg vaccination scars after moderna covid 19 vaccine
    40 Scar Reactivation Of Old Bcg Vaccination Scars After Moderna Covid 19 Vaccine, supplied by Moderna, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/40 scar reactivation of old bcg vaccination scars after moderna covid 19 vaccine/product/Moderna
    Average 86 stars, based on 1 article reviews
    40 scar reactivation of old bcg vaccination scars after moderna covid 19 vaccine - by Bioz Stars, 2026-06
    86/100 stars
    		  Buy from Supplier
    bcg scar  (STATA Corporation)
    99
    STATA Corporation bcg scar
    Characteristics of patients included in the cohort, with a detail of those responding and those not responding to ELISPOT PHA positive control.
    Bcg Scar, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bcg scar/product/STATA Corporation
    Average 99 stars, based on 1 article reviews
    bcg scar - by Bioz Stars, 2026-06
    99/100 stars
    		  Buy from Supplier
    bcg scar  (Blackwell Science Ltd)
    90
    Blackwell Science Ltd bcg scar
    Characteristics of patients included in the cohort, with a detail of those responding and those not responding to ELISPOT PHA positive control.
    Bcg Scar, supplied by Blackwell Science Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bcg scar/product/Blackwell Science Ltd
    Average 90 stars, based on 1 article reviews
    bcg scar - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Characteristics of patients included in the cohort, with a detail of those responding and those not responding to ELISPOT PHA positive control.

    Journal: PLoS ONE

    Article Title: Sensitivity of IFN-γ Release Assay to Detect Latent Tuberculosis Infection Is Retained in HIV-Infected Patients but Dependent on HIV/AIDS Progression

    doi: 10.1371/journal.pone.0001441

    Figure Lengend Snippet: Characteristics of patients included in the cohort, with a detail of those responding and those not responding to ELISPOT PHA positive control.

    Article Snippet: BCG scar and gender were forced into the final logistic model. Data were analysed using STATA 7 software (StataCorp LP, USA).

    Techniques: Enzyme-linked Immunospot, Control

    Analysis of the determinants of positive response to the ESAT6/CFP10 ELISPOT assay and to the TST (n = 247).

    Journal: PLoS ONE

    Article Title: Sensitivity of IFN-γ Release Assay to Detect Latent Tuberculosis Infection Is Retained in HIV-Infected Patients but Dependent on HIV/AIDS Progression

    doi: 10.1371/journal.pone.0001441

    Figure Lengend Snippet: Analysis of the determinants of positive response to the ESAT6/CFP10 ELISPOT assay and to the TST (n = 247).

    Article Snippet: BCG scar and gender were forced into the final logistic model. Data were analysed using STATA 7 software (StataCorp LP, USA).

    Techniques: Enzyme-linked Immunospot, Infection